Skip to main content
. 2024 May 28;8(5):826–835. doi: 10.1002/ags3.12829

TABLE 1.

Clinicopathological variables and preoperative IBI in CRC patients.

Variables N Preoperative IBI p value
Median (IQR)
Sex
Male 327 0.37 (0.12–1.37) 0.03 a ,*
Female 228 0.26 (0.08–1.53)
Median age (y)
>68 276 0.36 (0.11–1.33) 0.49 a
≤68 279 0.29 (0.1–1.53)
Neoadjuvant therapy
Yes 68 0.39 (0.12–2.21) 0.33 a
No 487 0.33 (0.1–1.39)
Obstruction/perforation/abscess
Present 41 6.84 (0.57–22.0) <0.0001 a ,*
Absent 514 0.29 (0.09–1.23)
Histological type
Differentiated 502 0.3 (0.1–1.23) <0.0001 a ,*
Undifferentiated 53 1.33 (0.33–20.1)
Location
Colon 339 0.4 (0.1–2.16) 0.02 a ,*
Rectum 216 0.27 (0.09–1.04)
Pathological T category
pT1/T2 189 0.15 (0.06–0.39) <0.0001 a ,*
pT3/T4 366 0.56 (0.17–3.72)
Venous invasion
Present 269 0.42 (0.12–2.98) 0.002 a ,*
Absent 286 0.25 (0.08–1.02)
Lymphatic invasion
Present 367 0.44 (0.12–2.75) <0.0001 a ,*
Absent 188 0.22 (0.08–0.77)
Lymph node metastasis
Present 225 0.58 (0.16–3.77) <0.0001 a ,*
Absent 330 0.25 (0.08–0.89)
Distant metastasis
Present 102 1.92 (0.44–9.37) <0.0001 a ,*
Absent 453 0.25 (0.08–0.9)
UICC stage classification
Stage I 157 0.13 (0.06–0.36) <0.0001 b ,*
Stage II 149 0.37 (0.14–1.76)
Stage III 147 0.34 (0.12–1.08)
Stage IV 102 1.92 (0.44–9.37)

Abbreviations: CRC, colorectal cancer; IBI, Inflammatory Burden Index; IQR, interquartile range.

a

Mann–Whitney test.

b

Kruskal–Wallis test.

*

p < 0.05.